Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 399 entries
View as:

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05651594 Org: User:
Start: 03/07/23 End: 03/30/26 Due: 03/30/27

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02334865 Org: User:
Start: 04/13/17 End: 05/19/26 Due: 05/19/27

Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05756166 Org: User:
Start: 02/16/24 End: 06/19/25 Due: 06/19/26

Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01527136 Org: User:
Start: 01/31/12 End: 10/31/14 Due: 10/31/15

GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07017829 Org: User:
Start: 12/01/25 End: 12/01/28 Due: 12/01/29

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04093323 Org: User:
Start: 11/13/24 End: 06/19/25 Due: 06/19/26

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00690924 Org: User:
Start: 07/17/08 End: 03/07/18 Due: 03/07/19

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03879694 Org: User:
Start: 06/17/19 End: 12/17/26 Due: 12/17/27

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01959698 Org: User:
Start: 04/17/14 End: 06/01/25 Due: 06/01/26

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT03011736 Org: User:
Start: 05/12/16 End: 12/24/18 Due: 12/24/19

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT05764330 Org: User:
Start: 04/24/24 End: 07/27/25 Due: 07/27/26

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01014546 Org: User:
Start: 04/30/10 End: 02/28/15 Due: 02/28/16

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00084864 Org: User:
Start: 09/30/02 End: 05/31/10 Due: 05/31/11

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT01014598 Org: User:
Start: 12/04/07 End: 05/01/17 Due: 05/01/18

Informational Intervention in Increasing Lactation Practices by African American Women

Phase: N/A Priority: Normal
NCT ID: NCT03680235 Org: User:
Start: 07/11/16 End: 06/30/19 Due: 06/30/20

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00054288 Org: User:
Start: 08/31/01 End: 06/30/09 Due: 06/30/10

A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity

Phase: N/A Priority: Normal
NCT ID: NCT03789877 Org: User:
Start: 01/16/19 End: 02/05/21 Due: 02/05/22

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05312255 Org: User:
Start: 06/28/22 End: 06/28/27 Due: 06/28/28

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Phase: N/A Priority: Normal
NCT ID: NCT00086931 Org: User:
Start: 09/30/03 End: 05/31/10 Due: 05/31/11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06011772 Org: User:
Start: 12/04/23 End: 12/04/26 Due: 12/04/27

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase: N/A Priority: Normal
NCT ID: NCT06995508 Org: User:
Start: 06/13/25 End: 06/13/31 Due: 06/13/32

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00004248 Org: User:
Start: 07/31/99 End: 05/31/01 Due: 05/31/02

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00093483 Org: User:
Start: 04/30/02 End: 12/31/09 Due: 12/31/10

Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002935 Org: User:
Start: 10/31/95 End: 09/30/07 Due: 09/30/08

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03192397 Org: User:
Start: 08/09/17 End: 05/21/27 Due: 05/21/28